Business Development

Proven Business Model

Medexus seeks to license or acquire products to address essential needs of patients and health care partners, leveraging our established North American sales force and infrastructure across a growing product portfolio

Organic Growth

Organic Growth

Driving growth in our existing product portfolio by improving market performance, adding new indications, and increasing reimbursement approvals

In-house Expertise

In-house Expertise

Sales, marketing, market access, medical affairs, patient programs, alliance management, regulatory, warehouse/supply, quality, manufacturing development

Product Development

Product Development

Applying our deep product knowledge to improve our existing products, expand their potential market, and enhance patient lives

Scalable Business Icon

Our Highly Scalable Business Platform

In addition to driving organic growth through sales of products within our existing portfolio, we are actively growing our product portfolio through new product launches, new product licensing and acquisitions.

Platform Icon

Strong Commercial Platform

Medexus has built a strong North American platform it will leverage to launch additional products

Expertise Icon

In-house Expertises

Regulatory, warehouse/supply, marketing, market access, medical affairs, patient programs

Focused Target Icon

Focused Targets in US and Canada

Medexus sales force and infrastructure specialize in and target specific therapeutic areas

  • Allergy
  • Dermatology
  • Hematology
  • Oncology
  • Rheumatology
  • Glioblastoma

Success Stories

Excellent Commercial Execution

Excellent Commercial Execution

  • Rasuvo
  • Rupall
  • Metoject
Disciplined Business 

Disciplined Business 

  • Treosulfan
  • Gleolan
  • Terbinafine

Existing Partners

medac GmbH
NX Development Corp
Pohl Boskamp

For Business Development or Partnering Inquiries, please email